Tag archive for ‘Copaxone Scenarios in 2014’
CFO Eyal Desheh, TEVA
Clive Minchom On Tuesday, December 10th, 2013

Teva Sees Two Copaxone Scenarios in 2014

– In its 2014 guidance Teva provides a pessimistic scenario with generic Copaxone competition, and an optimistic one with Copaxone exclusivity. – CEO Eyal Desheh, – Teva Pharmaceutical More...

Wordpress site Developed by Fixing WordPress Problems